Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Net Cash Flow (2016 - 2025)

Phibro Animal Health (PAHC) has 13 years of Net Cash Flow data on record, last reported at -$16.8 million in Q4 2025.

  • For Q4 2025, Net Cash Flow fell 188.84% year-over-year to -$16.8 million; the TTM value through Dec 2025 reached -$13.0 million, down 134.38%, while the annual FY2025 figure was -$1.4 million, 104.38% down from the prior year.
  • Net Cash Flow reached -$16.8 million in Q4 2025 per PAHC's latest filing, down from $4.6 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $23.1 million in Q4 2021 and bottomed at -$31.2 million in Q1 2023.
  • Average Net Cash Flow over 5 years is $1.3 million, with a median of $3.0 million recorded in 2022.
  • Peak YoY movement for Net Cash Flow: surged 755.51% in 2022, then tumbled 1010.17% in 2024.
  • A 5-year view of Net Cash Flow shows it stood at $23.1 million in 2021, then tumbled by 137.13% to -$8.6 million in 2022, then rose by 6.7% to -$8.0 million in 2023, then soared by 336.3% to $18.9 million in 2024, then tumbled by 188.84% to -$16.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Cash Flow were -$16.8 million in Q4 2025, $4.6 million in Q3 2025, and $6.5 million in Q2 2025.